Want to see BTSG full AI Analyst Report?
BTSG Stock Chart & Stats
$72.91
$3.07(4.40%)
At close: 4:00 PM EDT
$72.91
$3.07(4.40%)
Day’s Range― - ―
52-Week Range$19.01 - $73.75
Previous CloseN/A
Volume2.48M
Average Volume (3M)4.27M
Market Cap
$11.72B
Enterprise Value$11.25K
Total Cash (Recent Filing)$550.38M
Total Debt (Recent Filing)$238.34M
Price to Earnings (P/E)41.8
Beta1.13
Next Earnings
Oct 29, 2026EPS Estimate
0.45Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.43
Shares Outstanding196,258,400
10 Day Avg. Volume6,175,389
30 Day Avg. Volume4,274,686
Financial Highlights & Ratios
PEG Ratio-0.04
Price to Book (P/B)4.05
Price to Sales (P/S)0.59
P/FCF Ratio19.22
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$78.00Price Target Upside6.98% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering15
EPS Forecast (FY)1.7
Revenue Forecast (FY)$15.07B
Bulls Say, Bears Say
Bulls Say
Balance Sheet ImprovementMaterial deleveraging since 2023 meaningfully lowers interest and refinancing risk and increases financial flexibility to fund organic investments, M&A, or absorb policy shocks. A stronger capital base also supports sustained access to credit and reduces vulnerability to cyclical reimbursement swings.
Consistent Cash GenerationSolid operating cash flow and high FCF conversion provide durable internal funding for debt paydown, working capital, and growth initiatives. Reliable cash generation improves self-funded resilience to reimbursement headwinds and supports reinvestment in clinical quality and technology over the medium term.
Pharmacy & Specialty MomentumRapid specialty and infusion growth alongside expanding pharmacy gross profit reflect structural demand for complex, higher-acuity home-based therapies. Scale in specialty scripts and strong quality metrics create stickier customer relationships and differentiated service capabilities that support sustainable revenue and margin upside.
Bears Say
Margin CompressionA sustained decline in gross margins over several years signals rising cost intensity or pricing pressure that limits operating leverage. Persistent margin compression narrows the upside from revenue growth, makes profit more sensitive to reimbursement cuts, and constrains the company's ability to absorb inflation or invest without hurting returns.
Material Industry Headwinds (IRA/brand-to-generic)Quantified, multi-hundred-million-dollar impacts from IRA and brand-to-generic shifts represent structural revenue erosion in key pharmacy lines. These secular policy and product mix changes can persist for multiple years, forcing the company to reorganize commercial strategies or compress margins unless offset by new services or scale efficiencies.
Rising SG&A And PBM CompetitionHigher ongoing corporate investments increase the fixed cost base, reducing near-term operating leverage. Simultaneously, PBM and payer strategies to steer volume can structurally alter referral and reimbursement flows; together these factors raise execution risk and could blunt margin recovery despite revenue growth.
BrightSpring Health Services, Inc. News
BTSG FAQ
What was BrightSpring Health Services, Inc.’s price range in the past 12 months?
BrightSpring Health Services, Inc. lowest stock price was $19.01 and its highest was $73.75 in the past 12 months.
What is BrightSpring Health Services, Inc.’s market cap?
BrightSpring Health Services, Inc.’s market cap is $11.72B.
When is BrightSpring Health Services, Inc.’s upcoming earnings report date?
BrightSpring Health Services, Inc.’s upcoming earnings report date is Oct 29, 2026 which is in 88 days.
How were BrightSpring Health Services, Inc.’s earnings last quarter?
BrightSpring Health Services, Inc. released its earnings results on Jul 31, 2026. The company reported $0.45 earnings per share for the quarter, beating the consensus estimate of $0.396 by $0.054.
Is BrightSpring Health Services, Inc. overvalued?
According to Wall Street analysts BrightSpring Health Services, Inc.’s price is currently Undervalued.
Does BrightSpring Health Services, Inc. pay dividends?
BrightSpring Health Services, Inc. does not currently pay dividends.
What is BrightSpring Health Services, Inc.’s EPS estimate?
BrightSpring Health Services, Inc.’s EPS estimate is 0.45.
How many shares outstanding does BrightSpring Health Services, Inc. have?
BrightSpring Health Services, Inc. has 196,258,400 shares outstanding.
What happened to BrightSpring Health Services, Inc.’s price movement after its last earnings report?
BrightSpring Health Services, Inc. reported an EPS of $0.45 in its last earnings report, beating expectations of $0.396. Following the earnings report the stock price went down -18.071%.
Which hedge fund is a major shareholder of BrightSpring Health Services, Inc.?
Currently, no hedge funds are holding shares in BTSG
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
BrightSpring Health Services, Inc. Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$78.00 (6.98% Upside)
$78.00 (6.98% Upside)
Blogger Sentiment
Neutral
BTSG Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 1.5M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $1.7B over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 6.4%
Last 30 Days ▲ 58.3%
Last 30 Days ▲ 58.3%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
252.90%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
0.71%
Trailing 12-Months
Company Description
BrightSpring Health Services, Inc.
BrightSpring Health Services, Inc. operates across the United States, offering a range of healthcare solutions directly within patients' homes and local communities. The company's extensive platform focuses on providing crucial pharmacy and medical provider services, including both clinical care and supportive assistance, to individuals covered by Medicare, Medicaid, and private insurance. Patients receive care from a dedicated team of clinical professionals and licensed pharmacists. Formerly known as Phoenix Parent Holdings Inc., the company officially adopted the name BrightSpring Health Services, Inc. in May 2021. Founded in 1974, its headquarters are located in Louisville, Kentucky.
BTSG Company Deck
BTSG Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presented strong operational and financial momentum: double-digit revenue growth, a 45% increase in adjusted EBITDA, improved margins, solid segment performance in specialty, infusion and home health, successful integration contributions, and a meaningful cash proceeds event to strengthen the balance sheet. These positives are tempered by clear, quantified headwinds from IRA impacts and brand-to-generic conversions (~$600M aggregate headwind referenced), a Q1 rise in corporate investments, and ongoing PBM/payer competitive dynamics. Management characterized the headwinds as expected and actionable and reiterated guidance, suggesting confidence in execution and mitigation plans.View all BTSG earnings summariesBTSG Stock 12 Month Forecast
Average Price Target
$78.00
▲(6.98% Upside)
Technical Analysis
Ownership Overview
28.38% Insiders
31.70% Mutual Funds
0.85% Other Institutional Investors
18.28% Public Companies and Individual Investors